Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes.

计划入组 74 人 · 首次发布于 2024 年 6 月 13 日

DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (Ex Vivo Phase)

计划入组 50 人 · 首次发布于 2019 年 11 月 14 日

DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (In Vivo Phase)

计划入组 14 人 · 首次发布于 2021 年 8 月 18 日

Ex Vivo Expanded Allogeneic γδ T Cells therapy

ENOB-HV-31

Ex-vivo expanded allogeneic γδ T cell

IMPACTIV, INC.

United States

ENTE OSPEDALIERO OSPEDALI GALLIERA DI GENOVA

Italy

Sangamo Therapeutics

United States

Vivo Capital Secures $740 Million for Third Cycle of Healthcare Investment Fund

Nona Biosciences Expands CAR-T Partnership with Umoja Biopharma to Develop In Vivo Cell Therapies

Scribe Therapeutics' CRISPR Therapies Show Promise in Cardiometabolic Disease Treatment